Healthcare products company CCA Industries Inc (OTC:CAWW) disclosed on Monday that its income amounted to USD349,320 for the second quarter ended 31 May 2019.
This marks an improvement when compared with a loss of USD292,320 for the same period in fiscal 2018.
Revenues of USD5.458m were generated for the three months ended 31 May 2019,up over revenues of USD4.225m for the comparable period in fiscal 2018.
EBITDA of USD574,176 were recorded for the second quarter ended 31 May 2019, a rise from EBITDA of USD231,136 for the corresponding period in fiscal 2018.
Titan Pharmaceuticals announces Q2 2019 financial results
BioSpecifics Technologies reports Q2 2019 financial results
Nektar Therapeutics reports H1 2019 financial results
Medicure reports quarter ended 30 June 2019 financial results
Deciphera Pharmaceuticals' net loss narrows to USD21.5m in Q2 2019
CONMED Corporation to pay quarterly dividend of USD0.20 per share
Acerus and Aytu Bioscience to Co-promote Natesto in the United States
Amgen reports financial results for Q2 2019
Pfizer to integrate Upjohn with Mylan to establish new global pharmaceutical company